| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $500K | — |
| Cost of Revenue | $585K | — |
| Gross Profit | -$85K | — |
| R&D Expense | $19.8M | +81.0% |
| SG&A Expense | $25.6M | +106.4% |
| Operating Income | -$54.4M | -132.9% |
| Interest Expense | $53K | -99.9% |
| Pre-tax Income | -$56.1M | -56.4% |
| Net Income | -$50.3M |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $77.3M | +347.7% |
| Accounts Receivable | $200K | — |
| Current Assets | $82.6M | +336.3% |
| Total Assets | $87.0M | +339.8% |
| Total Liabilities | $7.6M | -62.7% |
| Stockholders' Equity | $61.7M | +3152.4% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$40.6M | -85.2% |
| Capital Expenditures | $1.5M | +2570.9% |
| Investing Cash Flow | -$3.7M | -6656.4% |
| Financing Cash Flow | $104.3M | +216.0% |
| Free Cash Flow | -$42.1M | -91.5% |
| -46.9% |